Could an antibody drug block the ebola vaccine? new study aims to find out.
NCT ID NCT05202288
First seen Jan 27, 2026 · Last updated May 23, 2026 · Updated 21 times
Summary
This study looks at whether giving an Ebola vaccine (Ervebo) together with an antibody drug (Inmazeb) still protects people from Ebola. The vaccine takes time to work, while the antibody acts fast, so combining them might offer better protection. About 132 healthy adults will take part to see if the vaccine's immune response is affected by the antibody.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBOLA VIRUS DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.